EcoDrugPlus

Ensembl ID : ENSATEG00000000988
Gene Symbol: YES1
1 Cross references
197 Possible Orthologues:

Ensembl ID : ENSATEG00000009544
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSATEG00000009516
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSATEG00000013545
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSATEG00000013839
Gene Symbol: -
Cross references: -
283 Possible Orthologues:

Ensembl ID : ENSATEG00000013158
Gene Symbol: -
Cross references: -
254 Possible Orthologues:

Ensembl ID : ENSATEG00000013171
Gene Symbol: -
Cross references: -
258 Possible Orthologues:

Ensembl ID : ENSATEG00000013184
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSATEG00000013316
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSATEG00000029232
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSATEG00000029095
Gene Symbol: -
Cross references: -
390 Possible Orthologues:

Ensembl ID : ENSATEG00000029491
Gene Symbol: -
Cross references: -
407 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).